Clickotine, A Personalized Smartphone App for Smoking Cessation: Initial Evaluation
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tobacco smoking is the leading cause of preventable death in the United States, and the annual economic burden attributable to smoking exceeds US $300 billion. Obstacles to smoking cessation include limited access and adherence to effective cessation interventions. Technology can help overcome these obstacles; many smartphone apps have been developed to aid smoking cessation, but few that conform to the US clinical practice guideline (USCPG) have been rigorously tested and reported in the literature. Clickotine is a novel smartphone app for smoking cessation, designed to deliver the essential features of the USCPG and engineered to engage smokers by personalizing intervention components. OBJECTIVE: Our objective was to assess the engagement, efficacy, and safety of Clickotine in an initial, single-arm study. Outcomes measured were indicators of engagement with the smartphone app (number of app opens, number of interactions with the Clickotine program, and weeks active with Clickotine), cessation outcomes of 7- and 30-day self-reported abstinence from smoking, and negative health events. METHODS: We recruited US residents between 18 and 65 years of age who owned an iPhone and smoked 5 or more cigarettes daily for the study via online advertising. Respondents were prescreened for eligibility by telephone and, if appropriate, directed to a Web portal to provide informed consent, confirm eligibility, and download the Clickotine app. Participants completed study assessments via the online portal at baseline and after 8 weeks. Data were collected in Amazon S3 with no manual data entry, and access to all data was maximally restrictive, logged, and auditable. RESULTS: A total of 416 participants downloaded the app and constituted the intention-to-treat (ITT) sample. On average, participants opened the Clickotine app 100.6 times during the 8-week study (median 69), logged 214.4 interactions with the Clickotine program (median 178), and remained engaged with Clickotine for 5.3 weeks (median 5). Among the ITT sample, 45.2% (188/416) reported 7-day abstinence and 26.2% (109/416) reported 30-day abstinence from smoking after 8 weeks. Completer analysis focused on 365 (87.7%) of the 416 enrolled participants who completed the 8-week questionnaire revealed that 51.5% (188/365) of completers reported 7-day abstinence and 29.9% (109/365) reported 30-day abstinence. Few adverse events, mostly consistent with nicotine withdrawal symptoms, were reported and overall no safety signal was detected. CONCLUSIONS: In this initial single-arm trial, Clickotine users appeared to demonstrate encouraging indicators of engagement in terms of the number of app opens, number of program interactions, and continued engagement over time. Clickotine users reported encouraging quit rates while reporting few adverse events. Future research is warranted to assess Clickotine's efficacy in a randomized controlled trial. TRIAL REGISTRATION: Clinicaltrials.gov NCT02656745; https://clinicaltrials.gov/ct2/show/NCT02656745 (Archived by WebCite at http://www.webcitation.org/6peTT4x60).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738 · cited 3×
“Baseline nicotine dependence level was measured using the Fagerstr m Test for Nicotine Dependence [41], administered in the online survey upon study enrollment.”
InfluentialDiMatteo, M. R. (2004) · Medical Care · doi:10.1097/01.mlr.0000114908.90348.f9 · Cited by 2,169 · cited 1×
“Furthermore, about 25% of patients looking to stop smoking do not take prescribed medicine as directed [9].”
Biochemical verification of tobacco use and cessation
Benowitz, N. L., III, P. J., Ahijevych, K., Jarvis, M. J., Hall, S., LeHouezec, J., Hansson, A., Lichtenstein, E., Henningfield, J., Tsoh, J., et al. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210123581 · Cited by 1,800
Shape of the relapse curve and long-term abstinence among untreated smokers
Hughes, J. R., Keely, J., & Naud, S. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00540.x · Cited by 1,414 · cited 3×
“However, most quit attempts fail: only 3% to 5% of smokers maintain abstinence up to 1 year after quitting [7].”
Interventions to Enhance Patient Adherence to Medication Prescriptions: Scientific Review
McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002) · JAMA · doi:10.1001/jama.288.22.2868 · Cited by 1,176
Effects of abstinence from tobacco: Valid symptoms and time course
Hughes, J. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701188919 · Cited by 801 · cited 1×
“The most commonly reported adverse events, fatigue and mood change, are expected nicotine withdrawal symptoms [50].”
Free, C., Knight, R., Robertson, S., Whittaker, R., Edwards, P., Zhou, W., Rodgers, A., Cairns, J., Kenward, M. G., & Roberts, I. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60701-0 · Cited by 728 · cited 1×
“Within the context of the USCPG features identified above, Clickotine delivers intervention components that have demonstrated efficacy in promoting smoking cessation: controlled breathing [33], personalized messaging [34,35], social engagement [36], encouragement of pharmacotherapy for cessation and of medication adhe…”
Predicting Smoking Cessation: Who Will Quit With and Without the Nicotine Patch
Kenford, S. L. (1994) · JAMA · doi:10.1001/jama.271.8.589 · Cited by 405
iPhone Apps for Smoking Cessation
Abroms, L. C., Padmanabhan, N., Thaweethai, L., & Phillips, T. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.10.032 · Cited by 365 · cited 2×
“The USCPG was developed for in-person clinical settings and, as such, not all parts of the guideline will apply for mobile phone apps [14].”
Bricker, J. B., Mull, K. E., Kientz, J. A., Vilardaga, R., Mercer, L. D., Akioka, K. J., & Heffner, J. L. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.07.006 · Cited by 340 · cited 5×
“…cessation does not appear to have been rigorously tested or reported, efficacy studies of several recently developed apps have been published (for example, apps that deliver Acceptance and Commitment Therapy components [16], or text message-based apps that provide support and interaction [17]).”
Influential
Cited by
Personalized medicine: motivation, challenges, and progress
Goetz, L. H., & Schork, N. J. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.05.006 · Cited by 976
Self-citationWhat is the clinical value of mHealth for patients?
Rowland, S. P., Fitzgerald, J. E., Holme, T., Powell, J., & McGregor, A. (2020) · npj Digital Medicine · doi:10.1038/s41746-019-0206-x · Cited by 454
Challenges in Participant Engagement and Retention Using Mobile Health Apps: Literature Review
Amagai, S., Pila, S., Kaat, A. J., Nowinski, C. J., & Gershon, R. C. (2022) · Journal of Medical Internet Research · doi:10.2196/35120 · Cited by 343
“Refer to Figure 1 for the study selection flowchart and Multimedia Appendix 1 [4-8,17-73] for characteristics of the studies.”
BackgroundDigital Therapeutics: An Integral Component of Digital Innovation in Drug Development
Sverdlov, O., van Dam, J., Hannesdottir, K., & Thornton‐Wells, T. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1036 · Cited by 147
Masaki, K., Tateno, H., Nomura, A., Muto, T., Suzuki, S., Satake, K., Hida, E., & Fukunaga, K. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0243-5 · Cited by 102
Metadata
- Authors
- Iacoviello, B. M., Steinerman, J. R., Klein, D. B., Silver, T. L., Berger, A. G., Luo, S. X., & Schork, N. J.
- Venue
- JMIR mHealth and uHealth
- Publisher
- JMIR Publications Inc.
- Published
- 2017-04-25
- Volume
- 5
- Issue
- 4
- Pages
- e56
- ISSN
- 2291-5222 (ISSN-L)
- OpenAlex
- W2607633511
- Cited by
- 115
- References
- 20
- FWCI
- 9.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clickotine, A Personalized Smartphone App for Smoking Cessation: Initial Evaluation. https://app.cochat.ai/papers/10.2196/mhealth.7226
- The paper
- Iacoviello, B. M., Steinerman, J. R., Klein, D. B., Silver, T. L., Berger, A. G., Luo, S. X., & Schork, N. J. (2017). Clickotine, A Personalized Smartphone App for Smoking Cessation: Initial Evaluation. JMIR mHealth and uHealth. https://doi.org/10.2196/mhealth.7226
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.